Médica Sur, S.A.B. de C.V. EBIT

The latest EBIT for MEDICAB.MX is $780M as of June 2026. That compares with $880M in the prior-year period — down 11.8% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside Médica Sur, S.A.B. de C.V.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MEDICAB.MX's EBIT moved from $880M to $780M — a 11.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Médica Sur, S.A.B. de C.V.'s operating scale or balance-sheet position.

Against its sector companies, MEDICAB.MX currently prints $780M for EBIT, while the sector average sits near $2.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Médica Sur, S.A.B. de C.V.'s growth, margins, and balance sheet.

A EBIT figure of $780M for MEDICAB.MX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting MEDICAB.MX's EBIT ($780M), review year-over-year change from $880M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.